BASF starts trial production of mononitrobenzene in Chongqing
Mononitrobenzene plant is one part of RMB 8 billion (approx. €860 million) BASF investment
BASF has begun trial operations at the mononitrobenzene plant within the integrated 400,000 metric ton methylene diphenyl diisocyanate (MDI) complex in Chongqing, China. Mononitrobenzene is a precursor for the production of MDI.
This MDI site covers an area of more than 50 hectares, including facilities of 400,000 metric tons per year of Mononitrobenzene, 300,000 metric tons per year of aniline, 400,000 metric tons per year of crude MDI, and an MDI splitter with a capacity of 400,000 metric tons per year.
Other news from the department manufacturing
![Newsletter](https://img.chemie.de/assets/ceurope/images/newsletter.png)
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.